Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.

Journal of neuroinflammation - 22 Mar 2014

St-Amour Isabelle, Paré Isabelle, Tremblay Cyntia, Coulombe Katherine, Bazin Renée, Calon Frédéric

Abstract excerpt

BACKGROUND: Intravenous immunoglobulin (IVIg) is currently in clinical study for Alzheimer's disease (AD). However, preclinical investigations are required to better understand AD-relevant outcomes of IVIg treatment and develop replacement therapies in case of unsustainable supply. METHODS: We in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Protein Precursor
Share to Anxiety
Share to CX3C Chemokine Receptor 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulins, Intravenous

Share to Immunologic Factors

Share to Memory Disorders

Share to Presenilin-1

Share to Receptors, Chemokine

Source

Open in PubMed Open full text

Identifiers

PMID: 24655894
DOI: 10.1186/1742-2094-11-54
PMCID: PMC3997966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24655894-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.PMID 24655894Read ↗

Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s diseaseSemantic proximity Read ↗

Therapeutic B-cell depletion reverses progression of Alzheimer's disease.Semantic proximity Read ↗

Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.Semantic proximity Read ↗

5xFAD-NSG mice: a preclinical Alzheimer model for human cell therapy studiesSemantic proximity Read ↗

Differential Effects of Chronic Immunosuppression on Behavioral, Epigenetic and Alzheimer’s Disease-Associated Markers in 3xtg-AD Mice Semantic proximity Read ↗

Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD miceSemantic proximity Read ↗

Age- and sex-dependent alterations in the peripheral immune system in the 3xTg-AD mouse model of Alzheimer's disease: Increased proportion of CD3+CD4-CD8- double-negative T cells in the bloodSemantic proximity Read ↗

Intravenous anti-Aβ immunotherapy acutely increases cerebral amyloid angiopathy and vascular damages in APOE4 miceSemantic proximity Read ↗

A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer’s diseaseSemantic proximity Read ↗

Oral TNFα Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model.Semantic proximity Read ↗

Suppression of AIMP1 protects cognition in Alzheimer's disease model mice 3xTg-AD.Semantic proximity Read ↗

Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.